A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response W Haenseler, SN Sansom, J Buchrieser, SE Newey, CS Moore, ... Stem cell reports 8 (6), 1727-1742, 2017 | 460 | 2017 |
A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis Y Miyazaki, R Li, A Rezk, H Misirliyan, C Moore, N Farooqi, M Solis, ... Plos one 9 (8), e105421, 2014 | 95 | 2014 |
Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis I Mexhitaj, MH Nyirenda, R Li, J O’Mahony, A Rezk, A Rozenberg, ... Brain 142 (3), 617-632, 2019 | 80 | 2019 |
Abnormal Frequency and Function of MR1-defined MAIT cells in Pediatric Multiple Sclerosis (S55. 007) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | 1 | 2019 |
Abnormal functional phenotypes of effector and regulatory T-cell subsets in pediatric-onset MS M Nyirenda, R Li, CS Moore, A Rozenberg, A Rezk, T Johnson, ... MULTIPLE SCLEROSIS JOURNAL 20, 314-315, 2014 | | 2014 |
Abnormal responses of CD8+ CD161high mucosal associated invariant T (MAIT) cells and CCR2+ CCR5+ CD4 T cells contribute to disrupted balance of effector and regulatory T cells … M Nyirenda, R Li, C Moore, A Rozenberg, A Rezk, T Johnson, ... Journal of Neuroimmunology 275 (1), 203-204, 2014 | | 2014 |
Altered adiponectin secretion in children may contribute to early disease mechanisms in multiple sclerosis L Poliquin-Lasnier, H Hanwell, C Belabani, J O'Mahony, C Moore, ... MULTIPLE SCLEROSIS JOURNAL 19 (11), 335-336, 2013 | | 2013 |
Among people with MS using gait aids, exercise shifts the balance of biomarkers, BDNF and IL-6, from inflammation to repair M Ploughman, AJ Devasahayam, LP Kelly, JB Williams, CS Moore MULTIPLE SCLEROSIS JOURNAL 26 (2_ SUPPL), 35-35, 2020 | | 2020 |
An alternate perspective on the roles of TIMPs and MMPs in pathology CS Moore, SJ Crocker The American journal of pathology 180 (1), 12-16, 2012 | 271 | 2012 |
Analysis of plasma using flow cytometry reveals increased immune cell-derived extracellular vesicles in untreated relapsing-remitting multiple sclerosis SN Blandford, NJ Fudge, CP Corkum, CS Moore Frontiers in immunology 13, 803921, 2022 | 7 | 2022 |
Apically localized PANX1 impacts neuroepithelial expansion in human cerebral organoids RJ Noort, H Zhu, RT Flemmer, CS Moore, TJ Belbin, JL Esseltine Cell Death Discovery 10 (1), 1-18, 2024 | | 2024 |
Apoptotic Mechanisms in Multiple Sclerosis: Diagnostic and Therapeutic Opportunities ALO Hebb, CS Moore, V Bhan, GS Robertson Apoptosis: Modern Insights into Disease from Molecules to Man, 473, 2010 | | 2010 |
Assessing the Balance Between Effector and Regulatory T cell Subsets in Pediatric Multiple Sclerosis (S55. 006) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
Astrocytes in multiple sclerosis SK Ludwin, VTS Rao, CS Moore, JP Antel Multiple sclerosis journal 22 (9), 1114-1124, 2016 | 132 | 2016 |
Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination CS Moore, R Milner, A Nishiyama, RF Frausto, DR Serwanski, ... Journal of neuroscience 31 (16), 6247-6254, 2011 | 150 | 2011 |
Asymmetry of brain excitability: a new biomarker that predicts objective and subjective symptoms in multiple sclerosis AR Chaves, EM Wallack, LP Kelly, RW Pretty, HD Wiseman, A Chen, ... Behavioural brain research 359, 281-291, 2019 | 43 | 2019 |
Basal versus responsiveness of serum brain-derived neurotrophic factor (BDNF): What does it mean for stroke recovery? T Chatterjee, LP Kelly, EM Wallack, AR Chaves, J Dawe, SN Rancourt, ... INTERNATIONAL JOURNAL OF STROKE 10, 78-79, 2015 | | 2015 |
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis D Henault, L Galleguillos, C Moore, T Johnson, A Bar-Or, J Antel Neurology 81 (20), 1768-1772, 2013 | 31 | 2013 |
Bruton Tyrosine Kinase Inhibitors decrease phosphorylation levels and pro-inflammatory cytokine production in healthy controls and relapse-remitting MS patient peripheral blood … R Benoit, N Fudge, C Moore MULTIPLE SCLEROSIS JOURNAL 29, 810-811, 2023 | | 2023 |
Cerebrospinal Fluid and Plasma Immune Cell Phenotyping Combined with Neurofilament Light Chain as Biomarkers of Inflammatory Activity and Disease Modifying Therapy … S Arsenault, C Moore, N Fudge, M Stefanelli, F Clift, L McGrath, ... Neurology 102 (17_supplement_1), 3664, 2024 | | 2024 |